241 related articles for article (PubMed ID: 24474556)
1. A mouse model for endometrioid ovarian cancer arising from the distal oviduct.
van der Horst PH; van der Zee M; Heijmans-Antonissen C; Jia Y; DeMayo FJ; Lydon JP; van Deurzen CH; Ewing PC; Burger CW; Blok LJ
Int J Cancer; 2014 Sep; 135(5):1028-37. PubMed ID: 24474556
[TBL] [Abstract][Full Text] [Related]
2. PTEN loss and HOXA10 expression are associated with ovarian endometrioid adenocarcinoma differentiation and progression.
Tanwar PS; Kaneko-Tarui T; Lee HJ; Zhang L; Teixeira JM
Carcinogenesis; 2013 Apr; 34(4):893-901. PubMed ID: 23276799
[TBL] [Abstract][Full Text] [Related]
3. Impact of oviductal versus ovarian epithelial cell of origin on ovarian endometrioid carcinoma phenotype in the mouse.
Wu R; Zhai Y; Kuick R; Karnezis AN; Garcia P; Naseem A; Hu TC; Fearon ER; Cho KR
J Pathol; 2016 Nov; 240(3):341-351. PubMed ID: 27538791
[TBL] [Abstract][Full Text] [Related]
4. Hormonal regulation of beta-catenin during development of the avian oviduct and its expression in epithelial cell-derived ovarian carcinogenesis.
Bae SM; Lim W; Jeong W; Lee JY; Kim J; Han JY; Bazer FW; Song G
Mol Cell Endocrinol; 2014 Jan; 382(1):46-54. PubMed ID: 24055276
[TBL] [Abstract][Full Text] [Related]
5. Mammalian target of rapamycin is a therapeutic target for murine ovarian endometrioid adenocarcinomas with dysregulated Wnt/β-catenin and PTEN.
Tanwar PS; Zhang L; Kaneko-Tarui T; Curley MD; Taketo MM; Rani P; Roberts DJ; Teixeira JM
PLoS One; 2011; 6(6):e20715. PubMed ID: 21695255
[TBL] [Abstract][Full Text] [Related]
6. WNT7A regulates tumor growth and progression in ovarian cancer through the WNT/β-catenin pathway.
Yoshioka S; King ML; Ran S; Okuda H; MacLean JA; McAsey ME; Sugino N; Brard L; Watabe K; Hayashi K
Mol Cancer Res; 2012 Mar; 10(3):469-82. PubMed ID: 22232518
[TBL] [Abstract][Full Text] [Related]
7. Mouse model of human ovarian endometrioid adenocarcinoma based on somatic defects in the Wnt/beta-catenin and PI3K/Pten signaling pathways.
Wu R; Hendrix-Lucas N; Kuick R; Zhai Y; Schwartz DR; Akyol A; Hanash S; Misek DE; Katabuchi H; Williams BO; Fearon ER; Cho KR
Cancer Cell; 2007 Apr; 11(4):321-33. PubMed ID: 17418409
[TBL] [Abstract][Full Text] [Related]
8. Evidence for a Novel Endometrioid Carcinogenic Sequence in the Fallopian Tube With Unique Beta-Catenin Expression.
Brouwer J; Strickland KC; Ning G; Schmelkin CB; Kolin DL; Hecht J; Nucci MR; Mourits MJ; Xian W; Crum CP
Int J Gynecol Pathol; 2020 Mar; 39(2):163-169. PubMed ID: 31574529
[TBL] [Abstract][Full Text] [Related]
9. Essential roles of mesenchyme-derived beta-catenin in mouse Müllerian duct morphogenesis.
Deutscher E; Hung-Chang Yao H
Dev Biol; 2007 Jul; 307(2):227-36. PubMed ID: 17532316
[TBL] [Abstract][Full Text] [Related]
10. Critical role of Wnt/β-catenin signaling in driving epithelial ovarian cancer platinum resistance.
Nagaraj AB; Joseph P; Kovalenko O; Singh S; Armstrong A; Redline R; Resnick K; Zanotti K; Waggoner S; DiFeo A
Oncotarget; 2015 Sep; 6(27):23720-34. PubMed ID: 26125441
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast growth factor 9 has oncogenic activity and is a downstream target of Wnt signaling in ovarian endometrioid adenocarcinomas.
Hendrix ND; Wu R; Kuick R; Schwartz DR; Fearon ER; Cho KR
Cancer Res; 2006 Feb; 66(3):1354-62. PubMed ID: 16452189
[TBL] [Abstract][Full Text] [Related]
12. Diverse mechanisms of beta-catenin deregulation in ovarian endometrioid adenocarcinomas.
Wu R; Zhai Y; Fearon ER; Cho KR
Cancer Res; 2001 Nov; 61(22):8247-55. PubMed ID: 11719457
[TBL] [Abstract][Full Text] [Related]
13. Oestrogen fuels the growth of endometrial hyperplastic lesions initiated by overactive Wnt/β-catenin signalling.
Goad J; Ko YA; Kumar M; Jamaluddin MFB; Tanwar PS
Carcinogenesis; 2018 Sep; 39(9):1105-1116. PubMed ID: 29912292
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-219-5p inhibits the proliferation, migration, and invasion of epithelial ovarian cancer cells by targeting the Twist/Wnt/β-catenin signaling pathway.
Wei C; Zhang X; He S; Liu B; Han H; Sun X
Gene; 2017 Dec; 637():25-32. PubMed ID: 28890378
[TBL] [Abstract][Full Text] [Related]
15. The stem-cell profile of ovarian surface epithelium is reproduced in the oviductal fimbriae, with increased stem-cell marker density in distal parts of the fimbriae.
Auersperg N
Int J Gynecol Pathol; 2013 Sep; 32(5):444-53. PubMed ID: 23896717
[TBL] [Abstract][Full Text] [Related]
16. MSX2 is an oncogenic downstream target of activated WNT signaling in ovarian endometrioid adenocarcinoma.
Zhai Y; Iura A; Yeasmin S; Wiese AB; Wu R; Feng Y; Fearon ER; Cho KR
Oncogene; 2011 Oct; 30(40):4152-62. PubMed ID: 21499300
[TBL] [Abstract][Full Text] [Related]
17. Lysophosphatidic Acid Initiates Epithelial to Mesenchymal Transition and Induces β-Catenin-mediated Transcription in Epithelial Ovarian Carcinoma.
Burkhalter RJ; Westfall SD; Liu Y; Stack MS
J Biol Chem; 2015 Sep; 290(36):22143-54. PubMed ID: 26175151
[TBL] [Abstract][Full Text] [Related]
18. Capn4 Enhances Osteopontin Expression through Activation of the Wnt/β-Catenin Pathway to Promote Epithelial Ovarian Carcinoma Metastasis.
Yang X; Sun J; Xia D; Can X; Liu L; Zhang J; Xu H; Du N; Liu W; Shen F; Zhang Z; Sun Y; Xi X
Cell Physiol Biochem; 2017; 42(1):185-197. PubMed ID: 28535511
[TBL] [Abstract][Full Text] [Related]
19. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q
Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967
[No Abstract] [Full Text] [Related]
20. [Expansion of secretory cells in the fallopian tubal epithelium in the early stages of the pathogenesis of ovarian serous carcinomas].
Asaturova AV; Ezhova LS; Faizullina NM; Adamyan LV; Khabas GN; Sannikova MV
Arkh Patol; 2017; 79(3):10-18. PubMed ID: 28631711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
